SCHEMBL30535367

SCHEMBL30535367

CS(=O)(=O)Nc1cc(Cl)cc(NC(=O)c2cc(C(=O)O)cs2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.45
▸ KMT2A Q03164 6/20 0.45
▸ HTT P42858 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CPT1A P50416 2/20 0.42
▸ CPT1B Q92523 2/20 0.42
▸ CPT2 P23786 1/20 0.38
▸ DAO P14920 1/20 0.38
▸ MAPT P10636 6/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ WDR5 P61964 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ LMNA P02545 3/20 0.37
▸ FABP4 P15090 1/20 0.36
▸ USP7 Q93009 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351103 1.00 MEN1 (0.45) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL30535443 0.89 MEN1 (0.50) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL25351564 0.89 MEN1 (0.50) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL31561130 0.85 CPT1A (0.44) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL25350572 0.85 ALDH1A1 (0.47) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL25367459 0.84 ALDH1A1 (0.51) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL30544027 0.84 ALDH1A1 (0.51) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL25351576 0.82 MEN1 (0.51) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL25351018 0.81 MEN1 (0.44) MEN1KMT2AHTTKDM4EALDH1A1
SCHEMBL30535715 0.81 MEN1 (0.44) MEN1KMT2AHTTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479138-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 — — EP disclosed
WO-2023154519-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-17 — — WO disclosed
Send feedback